Catalyst Pharmaceuticals, Inc. (FRA:CN2)

Catalyst Pharmaceuticals Revenue

Catalyst Pharmaceuticals had revenue of $148.39M USD in the quarter ending September 30, 2025, with 15.31% growth. This brings the company's revenue in the last twelve months to $578.20M, up 25.56% year-over-year. In the year 2024, Catalyst Pharmaceuticals had annual revenue of $491.73M with 23.49% growth.

• Revenue (ttm): $578.20M
• Revenue Growth: +25.56%
• P/S Ratio: 4.87
• Revenue / Employee: $3.19M
• Employees: 181
• Market Cap: 2.40B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	491.73M	93.53M	23.49%
Dec 31, 2023	398.20M	184.00M	85.90%
Dec 31, 2022	214.20M	73.37M	52.10%
Dec 31, 2021	140.83M	21.76M	18.27%
Dec 31, 2020	119.07M	16.77M	16.39%
Dec 31, 2019	102.31M	101.81M	20,361.20%
Dec 31, 2018	500.00K	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	-	-	-
Dec 31, 2010	488.96K	-	-
Dec 31, 2009	-	-	-
Dec 31, 2008	-	-	-
Dec 31, 2007	-	-	-
Dec 31, 2006	-	-	-
Dec 31, 2005	-	-	-